Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,305 papers from all fields of science
Search
Sign In
Create Free Account
Coxsackievirus A4 Ab:Titr:Pt:Ser:Qn
Known as:
Coxsackievirus A4 Ac [Titer] in Serum
, Coxsackievirus A4 As:Titer:Moment:Serum:Kwantitatief
, Coxsackievirus A4 Ab [Titer] in Serum
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Antibodies
Coxsackie Viruses
Coxsackievirus A4
Microbiology procedure
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma
Wenwei Chen
,
Lihong Chen
,
+5 authors
Jingfeng Liu
Tumor Biology
2016
Corpus ID: 11731188
The prognosis of hepatocellular carcinoma (HCC) after surgical resection remains unsatisfactory for the majority of HCC patients…
Expand
2016
2016
Overexpression of carboxypeptidase A 4 ( CPA 4 ) is associated with poor prognosis in patients with gastric cancer
Li-chao Sun
,
Chunguang Guo
,
+6 authors
Duxin Sun
2016
Corpus ID: 21730501
CarboxypeptidaseA4 (CPA4) is a zinc-containing exopeptidases, and its aberrant expression has been implicated in cancer…
Expand
2016
2016
The Role of Annexin A4 in Triple-Negative Breast Cancer Progression and Its Clinical Application.
Zhi-gang Zhang
,
Jian-ning Chen
,
Yu-de Wang
,
Jinpeng Gao
,
Yi Jin
Annals of Clinical and Laboratory Science
2016
Corpus ID: 25278175
BACKGROUND The expression of annexin A4 in triple-negative breast cancer (TNBC) remains unclear. In the present study, we…
Expand
2016
2016
Synthesis of a Novel Combretastatin A4 Analog with a 5,6,7-Trimethoxy Indole Substituted at the 3-Position
T. Rocha
2016
Corpus ID: 99617740
Combretastatin A4 (CA4) is an effective anti-cancer drug that works by inhibiting tubulin formation and thus decreases cellular…
Expand
2013
2013
A 4-3-Oxosteroid 5 , 8-Reductase Deficiency Described in Identical Twins with Neonatal Hepatitis
F.
,
J.
,
+6 authors
F. Balistren
2013
Corpus ID: 62803374
A new inborn error in bile acid synthesis, manifest in identical infant twins as severe intrahepatic cholestasis, is described…
Expand
2012
2012
Directive Microstrip Antennas for Specific Below −2.45 GHz Applications
E. Ávila-Navarro
,
Càndid Reig
2012
Corpus ID: 62786704
Microstrip printed antennas are the preferred choice in high data ratio modern communications, mainly at 2.45 GHz and above. In…
Expand
2007
2007
Pharmacokinetics, Safety, and Hydrolysis of Oral Pyrroloquinazolinediamines Administered in Single and Multiple Doses in Rats
Qigui Li
,
M. Kozar
,
+8 authors
D. Skillman
Antimicrobial Agents and Chemotherapy
2007
Corpus ID: 11976245
ABSTRACT Pyrroloquinazolinediamine (PQD) derivatives such as tetra-acetamide PQD (PQD-A4) and bis-ethylcarbamyl PQD (PQD-BE) were…
Expand
1998
1998
Topographic documentation of acute radiation morbidity.
J. Zimmermann
,
M. Seegenschmiedt
,
P. Niehoff
,
R. Galalae
,
B. Kimmig
Strahlentherapie und Onkologie (Print)
1998
Corpus ID: 2843576
BACKGROUND The clinical knowledge on the frequency and severity of acute radiation morbidity is very sparse. With established…
Expand
1996
1996
Enantioselectivitiy of the nitrile hydratase from Rhodococcus equi A4 towards substituted (R,S)-2-arylpropionitriles
L. Martínková
,
A. Stolz
,
H. Knackmuss
Biotechnology Letters
1996
Corpus ID: 23201832
Rhodococcus equi A4 cells containing a nitrile hydratase and an amidase converted (R,S)-2-(4-methoxyphenyl)-propionitrile into…
Expand
1977
1977
Application Of An Interactive Graphic Display In A CAD/CAM System For Mechanical Parts
W. Fischer
Other Conferences
1977
Corpus ID: 62212769
CAD/CAM systems aim to relieve designers, draftsmen and production planners of routine work by introducing data processing…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE